Godsey & Gibb Associates Novartis Ag Transaction History
Godsey & Gibb Associates
- $1.04 Billion
- Q3 2024
A detailed history of Godsey & Gibb Associates transactions in Novartis Ag stock. As of the latest transaction made, Godsey & Gibb Associates holds 191,338 shares of NVS stock, worth $21.2 Million. This represents 2.11% of its overall portfolio holdings.
Number of Shares
191,338
Previous 190,918
0.22%
Holding current value
$21.2 Million
Previous $20.3 Million
8.28%
% of portfolio
2.11%
Previous 2.1%
Shares
27 transactions
Others Institutions Holding NVS
# of Institutions
1,434Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.35 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.35 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$820 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$819 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$657 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $238B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...